Oakworth Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $727K | Buy |
2,008
+88
| +5% | +$30.1K | 0.03% | 122 |
|
|
2026
Q1 | $676K | Buy |
1,920
+66
| +4% | +$23.5K | 0.04% | 121 |
|
|
2025
Q4 | $607K | Buy |
1,854
+133
| +8% | +$42.2K | 0.03% | 121 |
|
|
2025
Q3 | $486K | Buy |
1,721
+278
| +19% | +$80.6K | 0.03% | 136 |
|
|
2025
Q2 | $403K | Sell |
1,443
-62
| -4% | -$17.6K | 0.03% | 143 |
|
|
2025
Q1 | $469K | Hold |
1,505
| – | – | 0.03% | 124 |
|
|
2024
Q4 | $392K | Hold |
1,505
| – | – | 0.03% | 144 |
|
|
2024
Q3 | $485K | Buy |
1,505
+283
| +23% | +$92.6K | 0.03% | 123 |
|
|
2024
Q2 | $382K | Sell |
1,222
-122
| -9% | -$35.8K | 0.03% | 133 |
|
|
2024
Q1 | $382K | Sell |
1,344
-101
| -7% | -$29.6K | 0.03% | 139 |
|
|
2023
Q4 | $416K | Buy |
1,445
+728
| +102% | +$198K | 0.03% | 129 |
|
|
2023
Q3 | $193K | Sell |
717
-1
| -0.1% | -$250 | 0.02% | 166 |
|
|
2023
Q2 | $159K | Buy |
718
+220
| +44% | +$51K | 0.01% | 194 |
|
|
2023
Q1 | $120K | Hold |
498
| – | – | 0.01% | 219 |
|
|
2022
Q4 | $131K | Hold |
498
| – | – | 0.01% | 198 |
|
|
2022
Q3 | $112K | Buy |
498
+132
| +36% | +$32K | 0.01% | 218 |
|
|
2022
Q2 | $89K | Sell |
366
-83
| -18% | -$20.3K | 0.01% | 246 |
|
|
2022
Q1 | $109K | Hold |
449
| – | – | 0.01% | 232 |
|
|
2021
Q4 | $101K | Hold |
449
| – | – | 0.01% | 263 |
|
|
2021
Q3 | $95K | Sell |
449
-1,151
| -72% | -$265K | 0.01% | 251 |
|
|
2021
Q2 | $390K | Sell |
1,600
-447
| -22% | -$110K | 0.04% | 123 |
|
|
2021
Q1 | $509K | Buy |
2,047
+250
| +14% | +$59.7K | 0.06% | 98 |
|
|
2020
Q4 | $413K | Buy |
1,797
+150
| +9% | +$34.6K | 0.05% | 106 |
|
|
2020
Q3 | $419K | Buy |
1,647
+351
| +27% | +$87K | 0.07% | 94 |
|
|
2020
Q2 | $306K | Hold |
1,296
| – | – | 0.06% | 112 |
|
|
2020
Q1 | $263K | Buy |
1,296
+693
| +115% | +$151K | 0.06% | 113 |
|
|
2019
Q4 | $144K | Buy |
603
+389
| +182% | +$85.7K | 0.03% | 181 |
|
|
2019
Q3 | $41K | Sell |
214
-13
| -6% | -$2.5K | 0.01% | 311 |
|
|
2019
Q2 | $42K | Sell |
227
-84
| -27% | -$15K | 0.01% | 334 |
|
|
2019
Q1 | $59K | Sell |
311
-102
| -25% | -$19.5K | 0.01% | 280 |
|
|
2018
Q4 | $80K | Sell |
413
-100
| -19% | -$19.5K | 0.02% | 241 |
|
|
2018
Q3 | $106K | Hold |
513
| – | – | 0.02% | 229 |
|
|
2018
Q2 | $95K | Hold |
513
| – | – | 0.02% | 226 |
|
|
2018
Q1 | $90K | Sell |
513
-21
| -4% | -$3.85K | 0.02% | 217 |
|
|
2017
Q4 | $94K | Sell |
534
-200
| -27% | -$35.4K | 0.02% | 221 |
|
|
2017
Q3 | $130K | Hold |
734
| – | – | 0.03% | 195 |
|
|
2017
Q2 | $126K | Hold |
734
| – | – | 0.03% | 198 |
|
|
2017
Q1 | $120K | Sell |
734
-122
| -14% | -$20.3K | 0.03% | 197 |
|
|
2016
Q4 | $123K | Buy |
856
+145
| +20% | +$21.8K | 0.04% | 193 |
|
|
2016
Q3 | $119K | Buy |
711
+10
| +1% | +$1.69K | 0.04% | 184 |
|
|
2016
Q2 | $111K | Buy |
701
+100
| +17% | +$15.5K | 0.04% | 189 |
|
|
2016
Q1 | $90K | Buy |
601
+115
| +24% | +$17.1K | 0.04% | 174 |
|
|
2015
Q4 | $79K | Hold |
486
| – | – | 0.03% | 165 |
|
|
2015
Q3 | $67K | Hold |
486
| – | – | 0.04% | 131 |
|
|
2015
Q2 | $86K | Hold |
486
| – | – | 0.04% | 125 |
|
|
2015
Q1 | $77K | Hold |
486
| – | – | 0.04% | 160 |
|
|
2014
Q4 | $77K | Hold |
486
| – | – | 0.04% | 153 |
|
|
2014
Q3 | $68K | Hold |
486
| – | – | 0.04% | 117 |
|
|
2014
Q2 | $58K | Hold |
486
| – | – | 0.04% | 126 |
|
|
2014
Q1 | $60K | Hold |
486
| – | – | 0.04% | 123 |
|
|
2013
Q4 | $55K | Buy |
+486
| New | +$55.3K | 0.04% | 114 |
|
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
Oakworth Capital's AMGN Position: Q2 2026 in Review
Oakworth Capital increased its Amgen (AMGN) stake by 4.6% in Q2 2026, buying an estimated $30.1K and bringing the position to 2,008 shares worth $727K. The position accounts for 0.03% of the portfolio, ranked #122.
Oakworth Capital first reported a position in AMGN in Q4 2013 and has held it in 51 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Oakworth Capital held 2,008 shares of Amgen worth $727K as of Q2 2026.
- Oakworth Capital bought 88 Amgen shares in Q2 2026, an estimated $30.1K.
- Amgen made up 0.03% of Oakworth Capital's portfolio in Q2 2026, its #122 holding.
- Oakworth Capital first reported a position in Amgen in Q4 2013 and has held it in 51 quarters since.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.